AI · អត្ថបទ
Every Cure and OpenEvidence Team Up to Revive Existing Drugs for Neglected Diseases
Unite.AI ·

មើលត្រួសៗ
Every Cure has partnered with OpenEvidence to find new uses for existing drugs, especially for diseases that lack commercial incentive. The work combines AI-based drug review with expert input, clinical trial recruitment, and sharing evidence with doctors. The partnership aims to help nonprofits pursue promising options without expecting normal profits.
ចំណុចសំខាន់ៗ
- Every Cure says about 18,000 diseases are known, but only about 4,000 have approved treatments.
- More than 300 million people worldwide have diseases with no FDA-approved treatment, according to its estimate.
- Drug repurposing finds new uses for approved drugs, which can be faster and cheaper than developing new ones.
- OpenEvidence provides proprietary models and biomedical content, including material from Nature.
ហេតុអ្វីវាសំខាន់
Many rare and neglected diseases have no treatment, and this partnership aims to make new uses for existing drugs reach patients.
ប្រភពដើម
Every Cure, OpenEvidence와 손잡고 비상업적 약물 재창출 추진
Unite.AI · Nov 17, 04:21 KST
Read on Unite.AI ↗AI summarized the original article. Check the original for accuracy. Copyright belongs to Unite.AI.
OpenEvidence · ចំណាត់ថ្នាក់ និងព័ត៌មានបន្ថែម
បន្ថែមពីវិស័យនេះ
- OpenAI Shows How to Claim a Shopify Store in ChatGPT
This video shows how to claim your business in ChatGPT by connecting your Shopify store. You can start in Business Hub or the Shopify App Store. After connecting, you can manage your business information to control how your store appears in ChatGPT.
OpenAI 공식 YouTube · Nov 21, 05:48 KST - OpenAI Sharply Cuts Success of Attacks on GPT-6.2 Astra and Sol Reasoning
OpenAI has greatly strengthened its defenses against attempts to pull the hidden reasoning out of its latest models, GPT-6.2 Astra and GPT-6.2 Sol. In its own internal tests, the success rate of these attacks fell sharply, and OpenAI says it is now bringing some of these improvements to GPT-6 Astra too.
The Decoder · Nov 21, 05:31 KST - Amazon Textract Insights Launches for Verifiable Document Data Extraction
Amazon has launched Amazon Textract Insights, a generative AI feature that pulls specific fields from documents. Users describe the data they want in plain language and get results with a confidence score and the page each value came from. Mixed files, such as a mortgage packet, can be split and matched automatically.
Amazon AWS Machine Learning blog · Nov 21, 05:22 KST - Etsy Sellers Close Shops Over New Policy Allowing AI Training on Their Work
Many longtime sellers on Etsy, the handmade goods marketplace, have closed their shops over new terms that let the company and its partners use seller content to train artificial intelligence. The terms take effect on Dec. 16. Etsy has defended the policy.
The New York Times · Nov 21, 05:19 KST